If the author’s manuscript is assessed as inappropriate to be published in his/her preferred journal, our editorial team may help the author in transferring the submission to a more appropriate Bentham Journal, through Bentham’s Manuscript Transfer Facility.
Transfer of Submission
Transfer of submission with Bentham’s Manuscript Transfer Facility is very simple.
The Author receives the transfer proposal by email - the transfer process is initiated by an affirmative response from the author to our transfer proposal.
The Authors’ manuscript is transferred to a suitable journal for initial editorial scrutiny.
The Author then receives an editorial decision from the journal.
Selection of another Journal
The Author is free to choose to submit the manuscript to a new journal by declining our transfer offer.
Our aim is to facilitate and develop rapid, effective and truly innovative solutions to facilitate our valued authors by enabling more options and better services to improve the publication process.
Ijeoma F. Uchegbu Department of Pharmaceutics University of London London (UK) Biography
Biography of Ijeoma F. Uchegbu
Ijeoma Uchegbu is Professor of Pharmaceutical Nanoscience at the UCL School of Pharmacy, University College London (UCL), Pro-Vice Provost for Africa and the Middle East, UCL and Chief Scientific Officer of Nanomerics. She obtained her PhD from the School of Pharmacy, University of London in 1994. In 2015, Ijeoma became UCL’s Pro-Vice Provost for Africa and The Middle East. Nanomerics was founded in 2010 by Ijeoma and Andreas G. Schätzlein. Nanomerics is a specialtiy pharmaceutical company focused on exploiting pharmaceutical nanotechnology platforms for medicines development. Ijeoma has been awarded various prizes for her work, notably the UK Department for Business Innovation Skills’ Women of Outstanding Achievement in Science Engineering and Technology award and the Royal Pharmaceutical Society’s Pharmaceutical Scientist of the Year 2012. Ijeoma was elected to the Controlled Release Society College of Fellows in 2013 and became an Eminent Fellow of the Academy of Pharmaceutical Sciences in 2013.